Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy (Q40886892)

24 September 2017

title

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy (English)

1 reference

adaptive radiation therapy

24 September 2017

main subject

0 references

author name string

Sartor CI

1

1 reference

24 September 2017

Strawderman MH

2

1 reference

24 September 2017

Lin XH

3

1 reference

24 September 2017

Kish KE

4

1 reference

24 September 2017

McLaughlin PW

5

1 reference

24 September 2017

Sandler HM

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

International Journal of Radiation Oncology Biology Physics

24 September 2017

published in

1 reference

24 September 2017

volume

38

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

941-947

1 reference

Fitting autoregressive models for prediction

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Radical surgery for advanced prostate cancer and for radiation failures

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Effect of external beam radiation therapyon serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

125Iodine prostate implants for recurrent carcinomas after external beam irradiation: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Boost treatment of the prostate using shaped, fixed fields

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900082-5

7 January 2021

10.1016/S0360-3016(97)00082-5

Identifiers

DOI

1 reference

24 September 2017

1 reference